Target intelligence / Profile preview

Immune system stimulation via adjuvants

Molecular classification
Other
01

Overview

Immune system stimulation via adjuvants" is not a specific molecule, receptor, or canonical therapeutic target; instead, it refers to the general pharmacological strategy of using adjuvants—substances that are added to vaccines or immunotherapies—to enhance or modulate immune responses to antigens. Adjuvants function through multiple mechanisms, including activation of pattern recognition receptors (such as TLRs and STING), induction of cytokines and chemokines, enhancement of antigen uptake and presentation by antigen-presenting cells, and polarization of T helper cell responses (favoring Th1, Th2, or Th17 pathways)[1][2][3][4][5]. While individual adjuvants (such as aluminum hydroxide, MF59, CpG ODNs, or QS-21) are specific molecules and can sometimes serve as therapeutic targets due to their interactions with innate immune receptors, the phrase provided does not name a discrete molecular target. Therefore, it is not considered a therapeutic target in the strict molecular pharmacology sense—rather, it is an immunological concept or functional strategy. The specific mechanism of action, disease roles, and safety concerns vary depending on the adjuvant used. Monitoring immune biomarkers (such as antibody isotypes, cytokine levels, and immune cell activation) is fundamental in evaluating the efficacy and safety of adjuvant use[2][4][5]. **Limitation:** The term "Immune system stimulation via adjuvants" is too broad and not specific to a single molecule, gene, or protein, and therefore does not qualify as a canonical therapeutic target or receptor. For structured biomedical annotations, listing specific adjuvants (e.g., "Aluminum hydroxide," "Toll-like receptor 9") would be more appropriate.

Other names
Immune stimulation by adjuvantsImmunostimulatory adjuvantsVaccine adjuvant stimulation
02

Mechanism of action

Induction of innate immune responses Activation of pattern recognition receptors (PRRs, e.g., TLRs, STING) Promotion of antigen uptake and presentation Formation of antigen depot Upregulation of cytokines and chemokines Maturation and activation of dendritic cells and other antigen-presenting cells Polarization of T helper cell responses (Th1, Th2, Th17)

03

Biological functions

Immune responseEnhancement of antigen presentationActivation of antigen-presenting cellsCytokine inductionPolarization of immune response (Th1, Th2, Th17)
04

Disease associations

InfectionCancerInflammationOther (as adjuvants are used to enhance vaccines for many infectious and non-infectious indications)
05

Safety considerations

Local injection site reactions (erythema, swelling)Allergic or hypersensitivity reactionsSystemic inflammation (in rare cases, cytokine storm)Poor induction of cellular immunity with some adjuvants (e.g., alum)Safety data for each adjuvant type and formulation must be evaluated individually
06

Interacting drugs

Aluminum salts (Alum)

8 more in the full profile.

07

Biomarkers

Cytokine profiles (e.g., IL-1β, IL-18, IL-4, IFN-γ)Chemokine expressionT cell proliferation markersAntibody titers (IgG subclasses)

Beyond the preview

Go deeper on Immune system stimulation via adjuvants.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system stimulation via adjuvants.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call